Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Revenue

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Net Sales ₹365 Cr₹333 Cr₹301 Cr₹278 Cr₹138 Cr

What is the latest Revenue of NATH BIOGENES (INDIA) ?

The latest Revenue ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹365 Cr
Mar2024₹333 Cr
Mar2023₹301 Cr
Mar2022₹278 Cr
Mar2013₹138 Cr

How is Revenue of NATH BIOGENES (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹365 Cr
9.71
Mar2024 ₹333 Cr
10.37
Mar2023 ₹301 Cr
8.26
Mar2022 ₹278 Cr
102.15
Mar2013 ₹138 Cr -

Compare Revenue of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹301.3 Cr -3.8% -3.4% -15.4% Stock Analytics
KAVERI SEED COMPANY ₹3,999.1 Cr -6% -14.1% -28.9% Stock Analytics
VENKYS (INDIA) ₹2,200.2 Cr 0.2% 5% -3.8% Stock Analytics
AVT NATURAL PRODUCTS ₹1,078.2 Cr 1.6% 1% -6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹900.5 Cr 0.1% 0.8% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹510.5 Cr -3% -3.9% -8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.8%

-3.4%

-15.4%

SENSEX

2.4%

1.5%

-4.3%


You may also like the below Video Courses